CPT code 64642 – Chemodenervation of one extremity

Key Takeaways

CPT code 64642 covers chemodenervation of one extremity using 1-4 muscles with a neurolytic agent such as botulinum toxin

64643 is the add-on code billed for each additional extremity (1-4 muscles) — it cannot be reported without a primary code (64642 or 64644)

Lack of medical necessity and missing prior authorization are frequent denial reasons for CPT code 64642 claims

HCPCS drug code J0585 (onabotulinumtoxinA) must be billed separately alongside the procedure code to capture the drug cost

Pabau’s claims management software supports electronic submission and denial tracking for chemodenervation claims

CPT Code 64642: Official descriptor and procedure overview

CPT code 64642 is defined by the American Medical Association as: “Chemodenervation of one extremity; 1-4 muscle(s).”

The procedure involves injecting a neurolytic agent directly into targeted muscles under EMG or ultrasound guidance, or by clinical landmark technique. Botulinum toxin is the agent used in virtually all 64642 claims. The code applies to one extremity per session. Each additional extremity with 1-4 muscles is reported with add-on code 64643.

What CPT code 64642 covers: Indications and included services

CPT code 64642 covers chemodenervation for conditions causing pathological muscle overactivity in an extremity. Covered indications include upper and lower limb spasticity (from stroke, cerebral palsy, multiple sclerosis, or traumatic brain injury) and focal dystonia of an extremity. Hyperhidrosis is not a 64642 indication. Eccrine gland chemodenervation is reported with 64650 (both axillae) or 64653 (other areas). Physical therapy and rehabilitation practices that perform these injections alongside other neurological services rely on precise indication coding to meet medical necessity thresholds.

The code includes the injection technique itself, including needle insertion and the physician’s intraservice work. Needle EMG guidance is reported separately with add-on 95874, and electrical stimulation guidance with 95873. Drug cost is not included and must be billed separately using the appropriate HCPCS J-code.

• Upper limb spasticity: flexor tone in the elbow, wrist, or finger muscles following stroke or brain injury
• Lower limb spasticity: equinovarus foot, calf spasm, or toe flexor involvement in ambulatory patients
• Focal dystonia: writer’s cramp or task-specific dystonia affecting hand or forearm muscles
• Cerebral palsy-related tone: scissor gait, toe-walking, or upper extremity posturing in pediatric and adult patients

What CPT 64642 does not cover: Exclusions and bundling rules

Knowing what falls outside CPT code 64642 prevents unbundling violations and claim rejections. Neck muscles use 64616; facial nerve muscles use 64612; chronic migraine prophylaxis uses 64615; larynx uses 64617; salivary glands use 64611; extraocular muscles use 67345.

• Neck muscles (excluding larynx): use CPT 64616, not 64642
• Extraocular muscles: use CPT 67345
• Salivary glands: use CPT 64611
• Eccrine glands: use CPT 64650 for both axillae or 64653 for other sites
• 5 or more muscles in one extremity: reported with 64644 (add-on 64645 for each additional extremity), not 64642
• Guidance: needle EMG guidance is reported with add-on 95874 and electrical stimulation guidance with 95873. Check current NCCI edits and payer policy before reporting any other guidance code.

Before adding another code to a 64642 claim, check the pair against the current National Correct Coding Initiative (NCCI) procedure-to-procedure edits. Billing a pair that the edit table bundles is unbundling, and it triggers automated claim edits.

CPT 64642 vs CPT 64643: Primary vs add-on code explained

64643 is the add-on code reported for each additional extremity (1-4 muscles) treated in the same session. It cannot be billed without a primary code, and payers will reject a standalone 64643 claim automatically. Code 64644 is a different primary code, used when 5 or more muscles in one extremity are injected.

Report 64643 on a separate line from 64642, with units equal to the number of additional extremities. The drug code (J0585 or equivalent) is reported once per drug per date of service, with the total units administered.

Related codes in the 6464x family: When to use each

The chemodenervation family spans several codes defined by anatomical site. Selecting a code for the wrong site or muscle count is a frequent cause of denials in neurology and PM&R billing.

HCPCS drug code J0585: Billing the botulinum toxin agent separately

J0585 is the HCPCS Level II code for onabotulinumtoxinA (Botox), billed per unit of the drug administered. Every toxin brand has its own J-code, and units are not interchangeable between products.

Bill J0585 units based on the number of units actually administered. Document the vial lot number, total units drawn, and any discarded waste in the procedure note. Medicare allows reporting of drug wastage when a single-dose vial is partially used – report the wasted units with modifier JW on a separate line. When no drug from a single-dose vial is discarded, Medicare requires modifier JZ on the drug line.

ICD-10 diagnosis codes required for CPT code 64642 claims

Every CPT code 64642 claim requires at least one ICD-10-CM diagnosis code that establishes medical necessity. The diagnosis must appear on the payer’s covered-condition list – for Medicare, that means the MAC’s Local Coverage Determination (LCD).

Off-label uses – even those widely accepted clinically – may be denied under Medicare LCDs. The diagnosis code alone does not establish medical necessity; the record must also document failed conservative treatments and functional goals.

Medicare coverage and CMS local coverage determinations

Medicare Part B covers CPT code 64642 when the claim meets the medical necessity criteria established by the patient’s MAC. There is no single national LCD for botulinum toxin injection – each MAC issues its own policy, and coverage requirements vary.

• Novitas Solutions (Jurisdictions H and L): CMS billing and coding article A52848 governs botulinum toxin claims, including 64642. It specifies covered diagnoses, frequency limitations, and documentation requirements.
• CGS Administrators (Jurisdiction 15, Kentucky and Ohio): CGS publishes a separate botulinum toxin LCD covering the same broad indication categories but with jurisdiction-specific covered-code lists.
• Palmetto GBA (Jurisdictions J and M) and WPS: Also maintain their own LCDs. Verify the current policy version for your jurisdiction before each submission cycle, as LCD updates take effect at the start of each fiscal year.

Medicare typically limits coverage to a minimum interval between injections – often 12 weeks for most spasticity indications. Billing more frequently than the LCD allows triggers a medical necessity denial regardless of documentation quality. Use the CMS Physician Fee Schedule lookup tool to confirm current payment rates and coverage indicators for 64642 in your geographic area.

Prior authorization requirements by payer

Prior authorization is required by most commercial payers for CPT code 64642. Insurance eligibility verification before scheduling the injection prevents the most common pre-service denial: discovering a PA requirement after the procedure has been performed.

• Medicare: Generally does not require prior authorization for 64642 as a physician-administered service, but medical necessity documentation must be available on request.
• Aetna (CPB 0113): Requires PA for botulinum toxin injections for most indications. The prior authorization request must include the diagnosis, failed conservative treatments, and functional assessment.
• UnitedHealthcare: Requires PA for chemodenervation procedures in most commercial plans. Check the UHC coverage portal for plan-specific requirements, as self-funded plans may differ from fully insured policies.
• Cigna and BCBS: PA requirements vary by plan. Most require prior authorization for spasticity indications.

Maintaining medical billing compliance means documenting the PA approval number in the claim and in the patient record. Practices that perform 64642 regularly benefit from standardized PA request templates. These include the diagnosis, relevant functional limitation scores, and the number of treatment sessions requested.

Documentation requirements: What must be in the medical record

Inadequate documentation is a frequent reason CPT code 64642 claims are denied or recouped on audit. Every procedure note must contain specific elements keyed to the LCD requirements – a generic injection note is insufficient.

• Diagnosis: ICD-10-CM code with supporting clinical findings (spasticity grade, dystonia severity, functional limitation)
• Medical necessity: Statement that conservative treatments (physical therapy, oral medications, bracing) have been tried and have not achieved adequate functional goals
• Muscle groups injected: Specific named muscles treated, listed by anatomical site and extremity (e.g., left biceps brachii, left brachioradialis)
• Toxin details: Brand name, lot number, total units drawn, total units administered, and any wasted units
• Injection technique: Guidance method used (EMG, ultrasound, clinical landmark) and number of injection sites per muscle
• Pre-treatment assessment: Tone measurement (Modified Ashworth Scale) and functional limitation
• Post-treatment plan: Follow-up interval, rehabilitation goals, and next assessment criteria
• Informed consent: Signed consent documenting discussed risks, including spread of toxin effect

Submitting a clean claim for 64642 starts with the procedure note, not the claim form. If the medical record cannot support the claim on audit, the payment will be recouped regardless of how correctly the claim was coded. Build note templates that prompt for each required element before the encounter closes.

CPT code 64642 reimbursement: Medicare fee schedule rates

Medicare reimburses CPT code 64642 under the Resource-Based Relative Value Scale (RBRVS). Rates are adjusted annually by CMS and vary by geographic location through the Geographic Practice Cost Indices (GPCI).

Multiply total RVUs by the Medicare conversion factor (which changes annually) and the applicable GPCI to calculate the locality-specific payment. Use the FastRVU lookup tool to retrieve current 2025/2026 payment rates for your location. Drug reimbursement for J0585 is calculated separately at the average sales price (ASP) plus 6%.

Pabau’s claims management software supports electronic submission of CPT code 64642 claims and tracks each claim’s status. When a claim is paid, the payment is recorded against the right invoice from the same Claims dashboard. Electronic claims submission via Claim.MD, Pabau’s US clearinghouse partner, routes 64642 claims to thousands of US payers with real-time eligibility checks and ERA posting.

Before you follow up with a payer, open the 64642 claim from the Claims dashboard and check its status. Then confirm the payment is recorded against the right invoice.

Streamline your chemodenervation billing workflow

Pabau connects electronic claim submission, denial tracking, and remittance posting in one platform. See how neurology and PM&R practices submit CPT 64642 claims and get paid faster.

Book a demo

Common claim denial reasons for CPT 64642 and how to avoid them

Denials for CPT code 64642 cluster around five predictable failure patterns. Each has a specific corrective action. Reactive denial management workflows catch these after the fact, but prevention at the point of documentation and authorization is more efficient.

• Lack of medical necessity: The diagnosis code is covered under the LCD. However, the procedure note does not document failed conservative treatments or a measurable functional limitation. Fix: add a structured pre-treatment assessment section to your procedure note template that forces documentation of prior treatment attempts.
• Missing or expired prior authorization: The claim is submitted without a PA number. Alternatively, the PA was obtained for a different diagnosis or number of units. Fix: verify PA requirements at every scheduling step and record the PA approval number in both the claim and the patient record.
• Incorrect ICD-10-CM code: The diagnosis code used is not on the payer’s covered-condition list, even if the clinical indication is similar. Fix: build a payer-specific ICD-10 code map for the most common 64642 indications and check it against each MAC’s LCD at least annually.
• Frequency limit exceeded: The interval since the last 64642 claim is less than the payer’s minimum reinjection interval (commonly 12 weeks for Medicare). Fix: track injection dates by patient and payer in your practice management system with alerts at the minimum frequency threshold.
• Bundling error: 64642 is submitted alongside a code that NCCI edits bundle with it. Fix: run a pre-submission NCCI edit check; remove any code that the edit table identifies as bundled with 64642.

Billing CPT 64642 with an E/M code: Modifier 25 rules

A separately identifiable evaluation and management service (99213-99215) can be billed on the same day as CPT code 64642. The E/M must be distinct from the routine pre-service assessment already included in the procedure.

Modifier 25 must be appended to the E/M code, not to 64642. It signals that the office visit addresses a separate, distinct problem beyond the injection encounter. The E/M note must document a chief complaint, history, examination, and medical decision-making. Together they must stand as a billable visit even if the injection had not occurred.

• When modifier 25 applies: A new neurological problem is evaluated at the same visit, or medication management for the underlying condition is separately documented. It also applies when a complication from a prior injection is assessed and managed.
• When modifier 25 does not apply: The E/M note only documents the patient’s response to the previous injection and the plan for today’s treatment. That is pre-service assessment, and it is bundled into 64642.
• Payer-specific caution: Some payers, especially Medicaid managed care plans, bundle E/M services with same-day procedures regardless of modifier 25. Verify payer policy before billing both codes.

The AAPC CPT code reference provides additional modifier guidance and bundling rules that apply to the 6464x family.

Conclusion

CPT code 64642 is the core code for extremity chemodenervation, and meeting its documentation burden means fewer avoidable denials. Four elements decide whether a 64642 claim pays on first submission. They are correct code selection, accurate ICD-10 pairing, timely prior authorization, and a procedure note that maps directly to LCD requirements.

Pabau’s claims management platform helps neurology and PM&R practices track authorization status, submit electronic claims, and monitor denial patterns by procedure code. To see how Pabau handles chemodenervation billing workflows end to end, book a demo with the team.

Continue your research

Need help understanding what goes on a clean claim? Clean claim submission guide covers every required element that keeps 64642 claims out of the denial queue.

Wondering how clearinghouses route your claims? Medical claims clearinghouse explained breaks down how electronic claim routing works between your practice and the payer.

Tracking down the source of repeated denials? Denial codes in medical billing maps the most common CARC and RARC codes back to their root causes. That way you fix the documentation instead of only resubmitting the claim.

Frequently Asked Questions